Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCARDIOVASCULAR

Protection against Myocardial Dysfunction Induced by Global Ischemia-Reperfusion by Antisense-Oligodeoxynucleotides Directed at β1-Adrenoceptor mRNA

Hongjiang Chen, Yuan Clare Zhang, Dayuan Li, M. Ian Phillips, Paullete Mehta, Min Shi and Jawahar L. Mehta
Journal of Pharmacology and Experimental Therapeutics August 2000, 294 (2) 722-727;
Hongjiang Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuan Clare Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dayuan Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Ian Phillips
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paullete Mehta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Shi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jawahar L. Mehta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Plasma catecholamine levels rise, and myocardial β1-adrenoceptor (β1-AR) sensitivity increases during ischemia. These factors enhance myocardial injury and cardiac dysfunction. β1-AR blockers are clinically used to protect heart against ischemia and to improve cardiac dysfunction in patients with ischemic heart disease, but these agents often cause intolerable side effects. To examine the potential cardioprotective effect of therapy with antisense-oligodeoxynucleotides directed at β1-AR mRNA (β1-AS-ODNs) during myocardial ischemia-reperfusion, Sprague-Dawley rats were treated with β1-AS-ODNs or inverted-oligodeoxynucleotides (IN-ODNs), each 200 μg/rat. Hearts were excised, perfused, and subjected to global ischemia (30 min) followed by reperfusion (30 min). Other rats were given selective β1-AR blocker atenolol (2 mg/kg) or saline before excising the hearts. Ischemia-reperfusion resulted in cardiac dysfunction, indicated by an increase in coronary perfusion pressure and left ventricular end-diastolic pressure and a decrease in developed left ventricular pressure, as well as evidence of lipid peroxidation in saline-treated rats (all P < .05 versus control values). Administration of AS-ODNs or atenolol, but not IN-ODNs, protected hearts against functional deterioration and lipid peroxidation (P < .05 versus saline or IN-ODNs treatment). AS-ODNs therapy appeared to be equivalent to atenolol in these effects. Expression of β1-AR protein as well as mRNA in the myocardium were markedly up-regulated after ischemia-reperfusion, and treatment with β1-AS-ODNs, but not atenolol, decreased the rise in enhanced expression of β1-AR. These observations imply that β1-AS-ODNs can ameliorate cardiac dysfunction after ischemia-reperfusion by reducing the expression of β1-AR in the ischemic-reperfused myocardium.

Footnotes

  • Send reprint requests to: J. L. Mehta, M.D., Ph.D., Professor of Medicine and Physiology, University of Florida, Department of Medicine, Box 100277, JHMHC, Gainesville, FL 32610. E-mail:mehta{at}medmac.ufl.edu

  • ↵1 This study was supported in part by a Merit Review Award from the Department of Veterans Affairs and a National Institutes of Health MERIT Award.

  • Abbreviations:
    β-AR
    β-adrenoreceptor
    AS-ODN
    antisense-oligodeoxynucleotide
    β1-AS-ODN
    antisense-oligodeoxynucleotide directed at β1-AR mRNA
    SHR
    spontaneously hypertensive rats
    IN-ODN
    inverted-oligodeoxynucleotide
    DOTAP
    1,2-bis(oleoyloxy)-3-(trimethylammonio)propane
    DOPE
    l-α-dioeoyl phosphatidylethanolamine
    CPP
    coronary perfusion pressure
    LVEDP
    left ventricular end diastolic pressure
    LVSP
    left ventricular systolic pressure
    dLVP
    developed left ventricular pressure
    RT-PCR
    reverse transcription-polymerase chain reaction
    MDA
    malondialdehyde
    • Received February 8, 2000.
    • Accepted April 4, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 294 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 294, Issue 2
1 Aug 2000
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Protection against Myocardial Dysfunction Induced by Global Ischemia-Reperfusion by Antisense-Oligodeoxynucleotides Directed at β1-Adrenoceptor mRNA
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCARDIOVASCULAR

Protection against Myocardial Dysfunction Induced by Global Ischemia-Reperfusion by Antisense-Oligodeoxynucleotides Directed at β1-Adrenoceptor mRNA

Hongjiang Chen, Yuan Clare Zhang, Dayuan Li, M. Ian Phillips, Paullete Mehta, Min Shi and Jawahar L. Mehta
Journal of Pharmacology and Experimental Therapeutics August 1, 2000, 294 (2) 722-727;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCARDIOVASCULAR

Protection against Myocardial Dysfunction Induced by Global Ischemia-Reperfusion by Antisense-Oligodeoxynucleotides Directed at β1-Adrenoceptor mRNA

Hongjiang Chen, Yuan Clare Zhang, Dayuan Li, M. Ian Phillips, Paullete Mehta, Min Shi and Jawahar L. Mehta
Journal of Pharmacology and Experimental Therapeutics August 1, 2000, 294 (2) 722-727;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • 4-Chloro ring-substituted synthetic cathinones
  • 14-3-3 Influences Nav1.5 Response to Anti-Arrhythmic Drugs
  • Inhaled Treprostinil Palmitil in the Sugen/Hypoxia Rat Model
Show more Cardiovascular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics